Literature DB >> 24107913

Coinfection of Pneumocystis jirovecii and invasive pulmonary aspergillosis in an immunocompromised patient: a diagnostic challenge.

Stefan Baumann1, Mark Reinwald, Dariush Haghi, Wolf-Karsten Hofmann, Dieter Buchheidt.   

Abstract

BACKGROUND: Invasive infections caused by Aspergillus fumigatus as well as Pneumocystis pneumonia are serious and often lethal diseases in severely immunocompromised patients. CASE REPORT: We report on a rare case of a pulmonary coinfection of Pneumocystis jirovecii and Aspergillus fumigatus in a 59-year-old female patient with a history of astrocytoma treated with high doses of corticosteroids and a subsequent CD4 lymphocyte count of 30/µl.
CONCLUSION: A heightened clinical awareness and a stringent and accurate diagnostic work-up encompassing diagnostic tools to detect even coincident fungal infections is crucial for sufficient and early antifungal treatment in immunocompromised patients with lung infiltrates.
© 2013 S. Karger GmbH, Freiburg.

Entities:  

Mesh:

Year:  2013        PMID: 24107913     DOI: 10.1159/000355168

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  3 in total

1.  Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome.

Authors:  Emilia Hardak; Irit Avivi; Lina Berkun; Ayelet Raz-Pasteur; Noa Lavi; Yuval Geffen; Mordechai Yigla; Ilana Oren
Journal:  Infection       Date:  2016-01-20       Impact factor: 3.553

2.  Molecular detection of Pneumocystis jirovecii using polymerase chain reaction in immunocompromised patients with pulmonary disorders in northeast of Iran.

Authors:  M Parian; A Fata; M J Najafzadeh; F Rezaeitalab
Journal:  Curr Med Mycol       Date:  2015-06

3.  Rapid and precise diagnosis of pneumonia coinfected by Pneumocystis jirovecii and Aspergillus fumigatus assisted by next-generation sequencing in a patient with systemic lupus erythematosus: a case report.

Authors:  Yili Chen; Lu Ai; Yingqun Zhou; Yating Zhao; Jianyu Huang; Wen Tang; Yujian Liang
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-06-26       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.